STOPP 2002 STOPP 2004 Womens Health Initiative -Studie 2. Studienarm
{"Image DocumentName": "STOPP 2002 STOPP 2004 Womens Health Initiative -Studie 2. Studienarm", "Image ImageDescription": "Premella\u00ae, Presomen comp \u00ae Premarin\u00ae,Presomen\u00ae 16739. hysterektomierte. Frauen. STOPP STOPP n = CEE mg + MPA 2.5 mg. \u00fcber 5.2 Jahre. n = Plazebo. \u00fcber 5.2 Jahre. n = CEE \u00fcber 6.8 Jahre. n = Plazebo. \u00fcber 6.8 Jahre. Ziel: Pr\u00e4vention kardiovaskul\u00e4re Krankheiten. osteoporotische Frakturen. Auswirkungen bez\u00fcglich Mamma/Colonkarzinom. Writing Group for the Womens Health Initiative Steering Committee. JAMA 2004; 291:", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}